CITC-SAUDI-ARABIA
19.12.2019 16:25:10 CET | Business Wire | Press release
Riyadh is set to become the Arab world’s first ever digital capital city. The announcement was revealed at the 23rd session of the Council of Arab Ministers of Communications and Information Technology, which took place on December 18 at The Ritz-Carlton hotel in Saudi Arabia’s capital.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191219005518/en/
The decision to name Riyadh the Arab Digital Capital follows the city’s prominent role in adopting and promoting the use of digital technologies to enhance socio-economic development, advance healthcare, improve education, and to ultimately increase community welfare, which helped to elevate the ICT sector's contribution to GDP to 4%. The Kingdom also climbed 16 places in World Economic Forum’s Global Competitive Index 2019 in terms of ICT adoption, and topped in the ease of doing business ranking according to the World Bank’s 2020 report.
The ‘Arab Digital Capital’ initiative seeks to encourage the creation of a stimulating ecosystem for investment in Information and Communications Technology (ICT), activate initiatives that develop knowledge within the ICT industry across Arab countries, and to adopt new initiatives that facilitate and enhance tech entrepreneurship in the Arab region.
Minister of Communications and Information Technology His Excellency Eng. Abdullah Al-Swaha extended congratulations to the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud, and to His Royal Highness Prince Muhammad bin Salman bin Abdulaziz, Crown Prince and Deputy Prime Minister and Minister of Defense. He hailed the great and unlimited support to the sector by the Kingdom’s good government, which highlighted it regionally and internationally. He also emphasized the acknowledgment as an addition added to the record of the Saudi ICT sector’s march, which has advanced the country’s digital infrastructure making it eligible for obtaining this title and precedence. This came in a keynote speech at the announcement ceremony attended by the Secretary-General of International Telecommunication Union, relevant Ministers, Arab Ambassadors to Riyadh and a number of interested ICT professionals and specialists.
Saudi Arabia is the region’s largest ICT market and ranks 13th globally, with a value of $28.7 billion in 2019 and strong growth in both the consumer and enterprise segments. Supported by a young and tech-savvy population, Saudi Arabia is a market of early technology adopters, with one of the highest social media penetrations in the world. Mobile subscribers stood at 43.8 million in 2019, representing a 129% penetration of the total population.
Following the launch of Vision 2030, the last few years have seen a significant acceleration in the proliferation of digital transformation initiatives. In 2019, Saudi Arabia was second among G20 countries for radio spectrum liberalization, with a subsequent positive impact on the quality of digital services provided by local operators experienced.
Supported by a 93% internet user penetration versus the global average of 53%, Saudi Arabia also became the first adopter of commercial 5G technology in the Middle East and North Africa, and the third largest globally – an achievement that is set to boost the adoption of other digitalization trends characterizing the Fourth Industrial Revolution. In parallel, the Kingdom is the 5th G20 country in internet speed, and jumped 91 places from 105th to 14th in the relevant global rankings, with a 51.8Mbps average speed.
Earlier this year, Ministry of Communications and Information Technology (MCIT) launched a five-year strategy aimed at accelerating the sector’s growth by 50% and elevating its contribution to GDP by $13.3 billion. Despite the global trend towards job disruption as a consequence of digitalization, the MCIT’s technology localization initiatives have significantly increased the ICT sector’s employment capacity in 2019.
The “Arab Digital Capital” award is a recognition of Saudi Arabia’s achievements in the ICT sector and is set to provide an even greater impetus to the country’s already busy regional and international agenda in the coming year. As the only Arab nation represented in the G20, Saudi Arabia will be hosting the G20 meetings throughout 2020, under the theme “Realizing Opportunities of the 21st Century for All.” The G20 Leaders Summit will take place on November 20-21, 2020 in Riyadh, the newly nominated Digital Capital of the Arab World.
Editor’s Note: new website for Riyadh Arab Digital Capital 2020 is at www.adcapitals.org
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20191219005518/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom